China Initiates Development of mRNA Vaccines

Sinopharm and Sinovac COVID-19 inactive vaccines are being called into question

A health worker shows a dose of the Chinese Sinopharm vaccine for COVID-19 disease, at a vaccination centre in the Jordanian capital Amman, on January 13, 2021. (KHALIL MAZRAAWI/AFP via Getty Images)
Share on facebook
Share on twitter
Share on whatsapp
While the efficacy of Chinese inactivated vaccines is in doubt, the Pfizer-BioNTech mRNA vaccine is still blocked on the Chinese Communist Party’s (CCP) approval process, and not allowed in mainland China. Meanwhile, state-owned Sinopharm announced it will develop an mRNA vaccine. On Sept. 6, state-owned First Financial said that the National Pharmaceutical Group Co., Ltd. (Sinopharm) has begun developing an mRNA variant vaccine and expe
Subscribe or log in to read the rest of this content.

Subscribe for Newsletter

Sign up to receive important news avoided by other media.

Scroll to Top